ACQUIREDT+30
Inhibrx Biosciences Inc · NASDAQ
+5,000 sh · $500.0K
Filed 23 Sept 2026SEC Form 4view source
- ACQUIREDT+30
Inhibrx Biosciences Inc · NASDAQ
+5,000 sh · $500.0K
Filed 17 Sept 2026SEC Form 4view source - ACQUIREDStale
Inhibrx Biosciences Inc · NASDAQ
+5,000 sh · $567.6K
Filed 8 Sept 2026SEC Form 4view source